LitAlert ~~

    • The Evolving Landscape of Pancreatic Cancer.
    • Krishnan M.
    • JCO Oncol Pract. 2022 Nov 10:OP2200636. doi: 10.1200/OP.22.00636. Epub ahead of print.
    • Study Suggests a PARP Inhibitors Has Wider Cancer Applications.
    • [No author given]
    • Inside Precision Medicine. Topics. Oncology. 2022 Nov 9.

    •• Original research:

    A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes.

    • Genomic and transcriptomic profiling indicates the prognosis significance of mutational signature for TMB-high subtype in Chinese patients with gastric cancer.
    • Cheng Y, Bu D, Zhang Q, Sun R, Lyle S, Zhao G, Dong L, Li H, Zhao Y, Yu J, Hao X.
    • J Adv Res. 2022 Nov 6:S2090-1232(22)00248-X. doi: 10.1016/j.jare.2022.10.019. Epub ahead of print.